Aspen Aerogels (NYSE:ASPN – Get Free Report) had its target price decreased by equities research analysts at Roth Mkm from $6.00 to $3.00 in a report released on Thursday,Benzinga reports. The firm presently has a “buy” rating on the construction company’s stock. Roth Mkm’s price target would indicate a potential downside of 4.03% from the stock’s previous close.
Several other brokerages also recently commented on ASPN. Canaccord Genuity Group dropped their target price on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Barclays decreased their price objective on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a report on Friday, November 7th. TD Cowen reduced their price target on shares of Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a research report on Thursday. Zacks Research raised Aspen Aerogels from a “strong sell” rating to a “hold” rating in a report on Thursday, January 15th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, December 29th. Three research analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $4.50.
View Our Latest Research Report on Aspen Aerogels
Aspen Aerogels Stock Down 0.4%
Aspen Aerogels (NYSE:ASPN – Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The construction company reported ($0.34) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.07). Aspen Aerogels had a negative net margin of 143.69% and a negative return on equity of 13.07%. The firm had revenue of $41.34 million for the quarter, compared to analysts’ expectations of $44.25 million. During the same period last year, the firm posted $0.14 EPS. Aspen Aerogels’s revenue was down 66.4% on a year-over-year basis. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. On average, analysts anticipate that Aspen Aerogels will post 0.17 EPS for the current year.
Institutional Investors Weigh In On Aspen Aerogels
Several hedge funds have recently made changes to their positions in ASPN. Peregrine Investment Management Inc. acquired a new position in Aspen Aerogels in the 3rd quarter worth about $4,176,000. Y Intercept Hong Kong Ltd bought a new stake in shares of Aspen Aerogels during the 2nd quarter worth $484,000. SG Americas Securities LLC grew its position in shares of Aspen Aerogels by 98.6% in the second quarter. SG Americas Securities LLC now owns 133,821 shares of the construction company’s stock valued at $792,000 after purchasing an additional 66,427 shares during the last quarter. Palogic Value Management L.P. grew its holdings in Aspen Aerogels by 43.5% in the 2nd quarter. Palogic Value Management L.P. now owns 610,000 shares of the construction company’s stock valued at $3,611,000 after buying an additional 185,000 shares during the last quarter. Finally, Federated Hermes Inc. bought a new position in Aspen Aerogels during the second quarter worth $10,459,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.
About Aspen Aerogels
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
Read More
- Five stocks we like better than Aspen Aerogels
- 3 Signs You May Want to Switch Financial Advisors
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- 1,500 Banks Just Handed the Fed Your Bank Account
- The Biggest IPO Ever… Open to Everyday Folks
- Read this or regret it forever
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
